 | • レポートコード：QFJ1-5790 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、高カリウム血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・高カリウム血症治療の市場動向 ・企業の競争状況、市場シェア ・高カリウム血症治療の種類別市場規模と予測2016-2027（経口、注射） ・高カリウム血症治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、ドラッグストア、オンライン薬局、その他） ・高カリウム血症治療の北米市場規模2016-2027（アメリカ、カナダ） ・高カリウム血症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・高カリウム血症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・高カリウム血症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・高カリウム血症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Steadfast MediShield、RSM Kilitch Pharma、Perrigo Company、Carolina Medical Products、Novel Laboratories、Pharmascience、Eli Lilly and Company、Relypsa、AstraZeneca、AdvaCare Pharma、Concordia Pharmaceuticals、Klarvoyant Biogenics） ・結論 |
Hyperkalaemia is a disease in which the levels of potassium are higher than normal. Minerals including potassium are essential for the body and are required for the normal functioning of the cells. The kidneys are responsible for the maintenance of potassium content in the body by balancing its intake as well as its excretion. If the intake of potassium is higher than the ability of the kidney to excrete it or if the functioning of the kidney decreases, hyperkalaemia is likely to occur.
Market Analysis and Insights: Global Hyperkalaemia Treatment Market
The global Hyperkalaemia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hyperkalaemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hyperkalaemia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hyperkalaemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hyperkalaemia Treatment market.
Global Hyperkalaemia Treatment Scope and Market Size
Hyperkalaemia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hyperkalaemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Injections
Segment by Application
Hospital Pharmacy
Retail Pharmacies
Drug Stores
Online Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Steadfast MediShield
RSM Kilitch Pharma
Perrigo Company
Carolina Medical Products
Novel Laboratories
Pharmascience
Eli Lilly and Company
Relypsa
AstraZeneca
AdvaCare Pharma
Concordia Pharmaceuticals
Klarvoyant Biogenics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hyperkalaemia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injections
1.3 Market by Application
1.3.1 Global Hyperkalaemia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Pharmacy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hyperkalaemia Treatment Market Perspective (2016-2027)
2.2 Hyperkalaemia Treatment Growth Trends by Regions
2.2.1 Hyperkalaemia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hyperkalaemia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hyperkalaemia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hyperkalaemia Treatment Industry Dynamic
2.3.1 Hyperkalaemia Treatment Market Trends
2.3.2 Hyperkalaemia Treatment Market Drivers
2.3.3 Hyperkalaemia Treatment Market Challenges
2.3.4 Hyperkalaemia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hyperkalaemia Treatment Players by Revenue
3.1.1 Global Top Hyperkalaemia Treatment Players by Revenue (2016-2021)
3.1.2 Global Hyperkalaemia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hyperkalaemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hyperkalaemia Treatment Revenue
3.4 Global Hyperkalaemia Treatment Market Concentration Ratio
3.4.1 Global Hyperkalaemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hyperkalaemia Treatment Revenue in 2020
3.5 Hyperkalaemia Treatment Key Players Head office and Area Served
3.6 Key Players Hyperkalaemia Treatment Product Solution and Service
3.7 Date of Enter into Hyperkalaemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hyperkalaemia Treatment Breakdown Data by Type
4.1 Global Hyperkalaemia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hyperkalaemia Treatment Forecasted Market Size by Type (2022-2027)
5 Hyperkalaemia Treatment Breakdown Data by Application
5.1 Global Hyperkalaemia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hyperkalaemia Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hyperkalaemia Treatment Market Size (2016-2027)
6.2 North America Hyperkalaemia Treatment Market Size by Type
6.2.1 North America Hyperkalaemia Treatment Market Size by Type (2016-2021)
6.2.2 North America Hyperkalaemia Treatment Market Size by Type (2022-2027)
6.2.3 North America Hyperkalaemia Treatment Market Size by Type (2016-2027)
6.3 North America Hyperkalaemia Treatment Market Size by Application
6.3.1 North America Hyperkalaemia Treatment Market Size by Application (2016-2021)
6.3.2 North America Hyperkalaemia Treatment Market Size by Application (2022-2027)
6.3.3 North America Hyperkalaemia Treatment Market Size by Application (2016-2027)
6.4 North America Hyperkalaemia Treatment Market Size by Country
6.4.1 North America Hyperkalaemia Treatment Market Size by Country (2016-2021)
6.4.2 North America Hyperkalaemia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hyperkalaemia Treatment Market Size (2016-2027)
7.2 Europe Hyperkalaemia Treatment Market Size by Type
7.2.1 Europe Hyperkalaemia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hyperkalaemia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hyperkalaemia Treatment Market Size by Type (2016-2027)
7.3 Europe Hyperkalaemia Treatment Market Size by Application
7.3.1 Europe Hyperkalaemia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hyperkalaemia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hyperkalaemia Treatment Market Size by Application (2016-2027)
7.4 Europe Hyperkalaemia Treatment Market Size by Country
7.4.1 Europe Hyperkalaemia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hyperkalaemia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hyperkalaemia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hyperkalaemia Treatment Market Size by Type
8.2.1 Asia-Pacific Hyperkalaemia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hyperkalaemia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hyperkalaemia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hyperkalaemia Treatment Market Size by Application
8.3.1 Asia-Pacific Hyperkalaemia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hyperkalaemia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hyperkalaemia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hyperkalaemia Treatment Market Size by Region
8.4.1 Asia-Pacific Hyperkalaemia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hyperkalaemia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hyperkalaemia Treatment Market Size (2016-2027)
9.2 Latin America Hyperkalaemia Treatment Market Size by Type
9.2.1 Latin America Hyperkalaemia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hyperkalaemia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hyperkalaemia Treatment Market Size by Type (2016-2027)
9.3 Latin America Hyperkalaemia Treatment Market Size by Application
9.3.1 Latin America Hyperkalaemia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hyperkalaemia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hyperkalaemia Treatment Market Size by Application (2016-2027)
9.4 Latin America Hyperkalaemia Treatment Market Size by Country
9.4.1 Latin America Hyperkalaemia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hyperkalaemia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hyperkalaemia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hyperkalaemia Treatment Market Size by Type
10.2.1 Middle East & Africa Hyperkalaemia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hyperkalaemia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hyperkalaemia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hyperkalaemia Treatment Market Size by Application
10.3.1 Middle East & Africa Hyperkalaemia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hyperkalaemia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hyperkalaemia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hyperkalaemia Treatment Market Size by Country
10.4.1 Middle East & Africa Hyperkalaemia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hyperkalaemia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Steadfast MediShield
11.1.1 Steadfast MediShield Company Details
11.1.2 Steadfast MediShield Business Overview
11.1.3 Steadfast MediShield Hyperkalaemia Treatment Introduction
11.1.4 Steadfast MediShield Revenue in Hyperkalaemia Treatment Business (2016-2021)
11.1.5 Steadfast MediShield Recent Development
11.2 RSM Kilitch Pharma
11.2.1 RSM Kilitch Pharma Company Details
11.2.2 RSM Kilitch Pharma Business Overview
11.2.3 RSM Kilitch Pharma Hyperkalaemia Treatment Introduction
11.2.4 RSM Kilitch Pharma Revenue in Hyperkalaemia Treatment Business (2016-2021)
11.2.5 RSM Kilitch Pharma Recent Development
11.3 Perrigo Company
11.3.1 Perrigo Company Company Details
11.3.2 Perrigo Company Business Overview
11.3.3 Perrigo Company Hyperkalaemia Treatment Introduction
11.3.4 Perrigo Company Revenue in Hyperkalaemia Treatment Business (2016-2021)
11.3.5 Perrigo Company Recent Development
11.4 Carolina Medical Products
11.4.1 Carolina Medical Products Company Details
11.4.2 Carolina Medical Products Business Overview
11.4.3 Carolina Medical Products Hyperkalaemia Treatment Introduction
11.4.4 Carolina Medical Products Revenue in Hyperkalaemia Treatment Business (2016-2021)
11.4.5 Carolina Medical Products Recent Development
11.5 Novel Laboratories
11.5.1 Novel Laboratories Company Details
11.5.2 Novel Laboratories Business Overview
11.5.3 Novel Laboratories Hyperkalaemia Treatment Introduction
11.5.4 Novel Laboratories Revenue in Hyperkalaemia Treatment Business (2016-2021)
11.5.5 Novel Laboratories Recent Development
11.6 Pharmascience
11.6.1 Pharmascience Company Details
11.6.2 Pharmascience Business Overview
11.6.3 Pharmascience Hyperkalaemia Treatment Introduction
11.6.4 Pharmascience Revenue in Hyperkalaemia Treatment Business (2016-2021)
11.6.5 Pharmascience Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Hyperkalaemia Treatment Introduction
11.7.4 Eli Lilly and Company Revenue in Hyperkalaemia Treatment Business (2016-2021)
11.7.5 Eli Lilly and Company Recent Development
11.8 Relypsa
11.8.1 Relypsa Company Details
11.8.2 Relypsa Business Overview
11.8.3 Relypsa Hyperkalaemia Treatment Introduction
11.8.4 Relypsa Revenue in Hyperkalaemia Treatment Business (2016-2021)
11.8.5 Relypsa Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Hyperkalaemia Treatment Introduction
11.9.4 AstraZeneca Revenue in Hyperkalaemia Treatment Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 AdvaCare Pharma
11.10.1 AdvaCare Pharma Company Details
11.10.2 AdvaCare Pharma Business Overview
11.10.3 AdvaCare Pharma Hyperkalaemia Treatment Introduction
11.10.4 AdvaCare Pharma Revenue in Hyperkalaemia Treatment Business (2016-2021)
11.10.5 AdvaCare Pharma Recent Development
11.11 Concordia Pharmaceuticals
11.11.1 Concordia Pharmaceuticals Company Details
11.11.2 Concordia Pharmaceuticals Business Overview
11.11.3 Concordia Pharmaceuticals Hyperkalaemia Treatment Introduction
11.11.4 Concordia Pharmaceuticals Revenue in Hyperkalaemia Treatment Business (2016-2021)
11.11.5 Concordia Pharmaceuticals Recent Development
11.12 Klarvoyant Biogenics
11.12.1 Klarvoyant Biogenics Company Details
11.12.2 Klarvoyant Biogenics Business Overview
11.12.3 Klarvoyant Biogenics Hyperkalaemia Treatment Introduction
11.12.4 Klarvoyant Biogenics Revenue in Hyperkalaemia Treatment Business (2016-2021)
11.12.5 Klarvoyant Biogenics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hyperkalaemia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injections
Table 4. Global Hyperkalaemia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hyperkalaemia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hyperkalaemia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hyperkalaemia Treatment Market Share by Regions (2016-2021)
Table 8. Global Hyperkalaemia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hyperkalaemia Treatment Market Share by Regions (2022-2027)
Table 10. Hyperkalaemia Treatment Market Trends
Table 11. Hyperkalaemia Treatment Market Drivers
Table 12. Hyperkalaemia Treatment Market Challenges
Table 13. Hyperkalaemia Treatment Market Restraints
Table 14. Global Hyperkalaemia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hyperkalaemia Treatment Market Share by Players (2016-2021)
Table 16. Global Top Hyperkalaemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperkalaemia Treatment as of 2020)
Table 17. Ranking of Global Top Hyperkalaemia Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hyperkalaemia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hyperkalaemia Treatment Product Solution and Service
Table 21. Date of Enter into Hyperkalaemia Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hyperkalaemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hyperkalaemia Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Hyperkalaemia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hyperkalaemia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hyperkalaemia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hyperkalaemia Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Hyperkalaemia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hyperkalaemia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hyperkalaemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hyperkalaemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hyperkalaemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hyperkalaemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hyperkalaemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hyperkalaemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hyperkalaemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hyperkalaemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hyperkalaemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hyperkalaemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hyperkalaemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hyperkalaemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hyperkalaemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hyperkalaemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hyperkalaemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hyperkalaemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hyperkalaemia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hyperkalaemia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hyperkalaemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hyperkalaemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hyperkalaemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hyperkalaemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hyperkalaemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hyperkalaemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hyperkalaemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hyperkalaemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hyperkalaemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hyperkalaemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hyperkalaemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hyperkalaemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Steadfast MediShield Company Details
Table 62. Steadfast MediShield Business Overview
Table 63. Steadfast MediShield Hyperkalaemia Treatment Product
Table 64. Steadfast MediShield Revenue in Hyperkalaemia Treatment Business (2016-2021) & (US$ Million)
Table 65. Steadfast MediShield Recent Development
Table 66. RSM Kilitch Pharma Company Details
Table 67. RSM Kilitch Pharma Business Overview
Table 68. RSM Kilitch Pharma Hyperkalaemia Treatment Product
Table 69. RSM Kilitch Pharma Revenue in Hyperkalaemia Treatment Business (2016-2021) & (US$ Million)
Table 70. RSM Kilitch Pharma Recent Development
Table 71. Perrigo Company Company Details
Table 72. Perrigo Company Business Overview
Table 73. Perrigo Company Hyperkalaemia Treatment Product
Table 74. Perrigo Company Revenue in Hyperkalaemia Treatment Business (2016-2021) & (US$ Million)
Table 75. Perrigo Company Recent Development
Table 76. Carolina Medical Products Company Details
Table 77. Carolina Medical Products Business Overview
Table 78. Carolina Medical Products Hyperkalaemia Treatment Product
Table 79. Carolina Medical Products Revenue in Hyperkalaemia Treatment Business (2016-2021) & (US$ Million)
Table 80. Carolina Medical Products Recent Development
Table 81. Novel Laboratories Company Details
Table 82. Novel Laboratories Business Overview
Table 83. Novel Laboratories Hyperkalaemia Treatment Product
Table 84. Novel Laboratories Revenue in Hyperkalaemia Treatment Business (2016-2021) & (US$ Million)
Table 85. Novel Laboratories Recent Development
Table 86. Pharmascience Company Details
Table 87. Pharmascience Business Overview
Table 88. Pharmascience Hyperkalaemia Treatment Product
Table 89. Pharmascience Revenue in Hyperkalaemia Treatment Business (2016-2021) & (US$ Million)
Table 90. Pharmascience Recent Development
Table 91. Eli Lilly and Company Company Details
Table 92. Eli Lilly and Company Business Overview
Table 93. Eli Lilly and Company Hyperkalaemia Treatment Product
Table 94. Eli Lilly and Company Revenue in Hyperkalaemia Treatment Business (2016-2021) & (US$ Million)
Table 95. Eli Lilly and Company Recent Development
Table 96. Relypsa Company Details
Table 97. Relypsa Business Overview
Table 98. Relypsa Revenue in Hyperkalaemia Treatment Business (2016-2021) & (US$ Million)
Table 99. Relypsa Recent Development
Table 100. AstraZeneca Company Details
Table 101. AstraZeneca Business Overview
Table 102. AstraZeneca Hyperkalaemia Treatment Product
Table 103. AstraZeneca Revenue in Hyperkalaemia Treatment Business (2016-2021) & (US$ Million)
Table 104. AstraZeneca Recent Development
Table 105. AdvaCare Pharma Company Details
Table 106. AdvaCare Pharma Business Overview
Table 107. AdvaCare Pharma Hyperkalaemia Treatment Product
Table 108. AdvaCare Pharma Revenue in Hyperkalaemia Treatment Business (2016-2021) & (US$ Million)
Table 109. AdvaCare Pharma Recent Development
Table 110. Concordia Pharmaceuticals Company Details
Table 111. Concordia Pharmaceuticals Business Overview
Table 112. Concordia Pharmaceuticals Hyperkalaemia Treatment Product
Table 113. Concordia Pharmaceuticals Revenue in Hyperkalaemia Treatment Business (2016-2021) & (US$ Million)
Table 114. Concordia Pharmaceuticals Recent Development
Table 115. Klarvoyant Biogenics Company Details
Table 116. Klarvoyant Biogenics Business Overview
Table 117. Klarvoyant Biogenics Hyperkalaemia Treatment Product
Table 118. Klarvoyant Biogenics Revenue in Hyperkalaemia Treatment Business (2016-2021) & (US$ Million)
Table 119. Klarvoyant Biogenics Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hyperkalaemia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injections Features
Figure 4. Global Hyperkalaemia Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Drug Stores Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Hyperkalaemia Treatment Report Years Considered
Figure 11. Global Hyperkalaemia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Hyperkalaemia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Hyperkalaemia Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Hyperkalaemia Treatment Market Share by Regions (2022-2027)
Figure 15. Global Hyperkalaemia Treatment Market Share by Players in 2020
Figure 16. Global Top Hyperkalaemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperkalaemia Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Hyperkalaemia Treatment Revenue in 2020
Figure 18. Global Hyperkalaemia Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Hyperkalaemia Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Hyperkalaemia Treatment Market Share by Type (2016-2027)
Figure 22. North America Hyperkalaemia Treatment Market Share by Application (2016-2027)
Figure 23. North America Hyperkalaemia Treatment Market Share by Country (2016-2027)
Figure 24. United States Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hyperkalaemia Treatment Market Share by Type (2016-2027)
Figure 28. Europe Hyperkalaemia Treatment Market Share by Application (2016-2027)
Figure 29. Europe Hyperkalaemia Treatment Market Share by Country (2016-2027)
Figure 30. Germany Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hyperkalaemia Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Hyperkalaemia Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Hyperkalaemia Treatment Market Share by Region (2016-2027)
Figure 40. China Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hyperkalaemia Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Hyperkalaemia Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Hyperkalaemia Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hyperkalaemia Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Hyperkalaemia Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Hyperkalaemia Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Hyperkalaemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Steadfast MediShield Revenue Growth Rate in Hyperkalaemia Treatment Business (2016-2021)
Figure 60. RSM Kilitch Pharma Revenue Growth Rate in Hyperkalaemia Treatment Business (2016-2021)
Figure 61. Perrigo Company Revenue Growth Rate in Hyperkalaemia Treatment Business (2016-2021)
Figure 62. Carolina Medical Products Revenue Growth Rate in Hyperkalaemia Treatment Business (2016-2021)
Figure 63. Novel Laboratories Revenue Growth Rate in Hyperkalaemia Treatment Business (2016-2021)
Figure 64. Pharmascience Revenue Growth Rate in Hyperkalaemia Treatment Business (2016-2021)
Figure 65. Eli Lilly and Company Revenue Growth Rate in Hyperkalaemia Treatment Business (2016-2021)
Figure 66. Relypsa Revenue Growth Rate in Hyperkalaemia Treatment Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Hyperkalaemia Treatment Business (2016-2021)
Figure 68. AdvaCare Pharma Revenue Growth Rate in Hyperkalaemia Treatment Business (2016-2021)
Figure 69. Concordia Pharmaceuticals Revenue Growth Rate in Hyperkalaemia Treatment Business (2016-2021)
Figure 70. Klarvoyant Biogenics Revenue Growth Rate in Hyperkalaemia Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年） Cervical dystonia/spasmodic torticollis is the involuntary muscular contraction of the neck, which leads to head twist. It is a rare neurological disorder that affects all age groups and most often it affects middle-aged people. Market Analysis and Insights: Global Cervical Dystonia Treatment Marke…- 世界の風邪薬市場規模・現状・予測（2021年-2027年） This report focus on OTC drugs and wellness drugs to treat cold symptoms and respiratory infections. Market Analysis and Insights: Global Cold Treatment Drug Market The global Cold Treatment Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% …
- 世界のヘモグロビン症用治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hemoglobinopathy Treatment Drug Market The global Hemoglobinopathy Treatment Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
- 世界の網膜障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Retinal Disorder Treatment Market The global Retinal Disorder Treatment market size is projected to reach US$ 10890 million by 2027, from US$ 7860.7 million in 2020, at a CAGR of 4.3% during 2021-2027. With industry-standard accuracy in analysis and high data int…
- 世界の副甲状腺機能低下症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypoparathyroidism Treatment Market The global Hypoparathyroidism Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…